| Tyyppi : |
Lehti |
|
| Tutkimus Joukkueet : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Tekijät : |
Alarie H, Friciu M, Leclair G. |
| Otsikko : |
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions. |
| Numero : |
Can J Hosp Pharm ;71,2/152-154 2018 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Dapsone
|
 |
 |
 |
 |
60 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
 |
| 90 |
 |
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
2 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
